fangchinoline has been researched along with Diabetic Retinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H; Wu, Q; Zhou, M | 1 |
1 other study(ies) available for fangchinoline and Diabetic Retinopathy
| Article | Year |
|---|---|
Fangchinoline Ameliorates Diabetic Retinopathy by Inhibiting Receptor for Advanced Glycation End-Products (RAGE)-Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB) Pathway in Streptozotocin (STZ)-Induced Diabetic Rats.
Topics: Animals; Apoptosis; Benzylisoquinolines; Cytokines; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glycated Hemoglobin; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Retina; Signal Transduction | 2019 |